Dubai Electricity and Water Authority (DEWA) has started to receive applications for participation in the 27th edition of the Water, Energy, Technology, and Environment Exhibition (WETEX). Organised by DEWA in line with the directives of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, and under the patronage of HH Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Supreme Council of Energy, the exhibition will take place from 30 S...

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announced detailed results from the Phase 3, randomized, placebo-controlled VERIFY study evaluating rusfertide in patients with polycythemia vera (PV), which met the primary and all key secondary endpoints. The data will be presented as a late-breaking oral presentation at the 61st American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session (LBA3) at 2:09 pm CDT today. PV is characteriz...

Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), in collaboration with the Global Antibiotic Research & Development Partnership (GARDP), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for zoliflodacin, the investigational first-in-class, single dose, spiropyrimidinetrione oral antibiotic for the treatment of uncomplicated gonorrhea in adults and pediatric patients 12 years and older. If approv...

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of...

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (D...

KAYTUS, a leading provider of end-to-end AI and liquid cooling solutions, has announced the release of the enhanced KSManage V2.3, its advanced device management platform for AI data centers. The latest version introduces expanded monitoring and control capabilities tailored for GB200 and B200 systems, including integrated liquid cooling detection features. Leveraging intelligent automation, KSManage V2.3 enables AI data centers to operate with greater precision, efficiency, and sustainability,...

Horizon3.ai, the company behind the NodeZero® Autonomous Security Platform, today announced a $100 million Series D funding round led by NEA, with participation from SignalFire, Craft Ventures and 9Yards Capital. As part of the investment, Lila Tretikov, Partner and Head of AI Strategy at NEA and former Deputy CTO of Microsoft, will join the Horizon3.ai Board of Directors. “Over the past four years, we’ve proven that using AI to hack companies isn’t science fiction—it’s real, and it’s deliver...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. “Thousands of people with CF across the EU may now benefit from this new, once-daily medicine, which has demonstrated further improvement in CFTR pr...

Palantir Technologies Inc. (NASDAQ: PLTR) today announced a multi-year partnership with Fedrigoni, a global reference manufacturer of specialty papers for packaging and other creative applications, self-adhesive labels, graphic supports for visual communication, and RFID. This strategic alliance aims to accelerate Fedrigoni's digital transformation by leveraging advanced AI capabilities and Palantir's innovative solutions. Initially focused on stock optimization and demand forecasting, the part...